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A B S T R A C T
Exposures to high levels of environmental selenium have been associated with motor neuron disease in
both animals and humans and high levels of selenite have been identiﬁed in the cerebrospinal ﬂuid of
patients with amyotrophic lateral sclerosis (ALS). We have shown previously that exposures to high
levels of sodium selenite in the environment of Caenorhabditis elegans adult animals can induce
neurodegeneration and cell loss resulting in motor deﬁcits and death and that this is at least partially
caused by a reduction in cholinergic signaling across the neuromuscular junction. Here we provide
evidence that reduction in insulin/insulin-like (IIS) signaling alters response to high dose levels of
environmental selenium which in turn can regulate the IIS pathway. Most speciﬁcally we show that
nuclear localization and thus activation of the DAF-16/forkhead box transcription factor occurs in
response to selenium exposure although this was not observed in motor neurons of the ventral cord. Yet,
tissue speciﬁc expression and generalized overexpression of DAF-16 can partially rescue the
neurodegenerative and behavioral deﬁcits observed with high dose selenium exposures in not only
the cholinergic, but also the GABAergic motor neurons. In addition, two modiﬁers of IIS signaling, PTEN
(phosphatase and tensin homolog, deleted on chromosome 10) and PINK1 (PTEN-induced putative
kinase 1) are required for the cellular antioxidant reduced glutathione to mitigate the selenium-induced
movement deﬁcits. Studies have suggested that environmental exposures can lead to ALS or other
neurological diseases and this model of selenium-induced neurodegeneration developed in a genetically
tractable organism provides a tool for examining the combined roles of genetics and environment in the
neuro-pathologic disease process.
 2014 The Authors. Published by Elsevier Inc. 
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Selenium (Se) is an essential micronutrient with a narrow
recommended dietary range. Insufﬁcient dietary Se can be lethal
contributing to the cardiomyopathy of Keshan Disease and the
osteochondropathy of Kashin-Beck disease (Lee and Jeong, 2012).
And, while supranutritional levels of Se can also be lethal (Spiller
and Pﬁefer, 2007), high levels of selenite [Se(IV)] and other Se
compounds such as Ebselen have been used effectively as cancer
therapeutics (Sanmartı´n et al., 2012; Fairweather-Tait et al., 2011).
During the course of a number of cancer treatment trials, it was
observed that the higher doses of Se capable of reducing the
incidence of various cancers were positively associated with
increases in fasting glucose levels and type 2 diabetes (Rocourt and
Cheng, 2013; Steinbrenner, 2013). Based on these and othere.
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levels alter diabetic status and include a role for selenoproteins
(Rayman and Stranges, 2013; Labunskyy et al., 2011). Selenopro-
teins are proteins that incorporate Se in the form of selenocysteine
and include the antioxidant proteins: glutathione peroxidase
(GPx), thioredoxin reductase (TrxR), and selenoprotein P (SeP).
Increased levels of SeP have been observed in diabetic and pre-
diabetic humans (Yang et al., 2011), and in animal models
overexpression of GPx induced insulin resistance (McClung et
al., 2004). Targeted knockouts of these selenoproteins in animals
models are associated with neurodegeneration (Caito et al., 2011;
Wirth et al., 2010), and lower levels are found in individuals with
Alzheimer’s and other neurological diseases (Vinceti et al., 2013;
Zhang et al., 2010).
Supranutritional levels of Se can also exert effects on the
insulin/insulin-like growth factor (IGF)-1 signaling (IIS) pathway
via the induction of hydrogen peroxide (H2O2) and reactive oxygen
species (ROS) formation (Steinbrenner, 2013). High levels of
exogenously applied H2O2 prevent phosphorylation/activation of
AKT1/PKB (Iwakami et al., 2011), a serine/threonine kinase that is a
downstream mediator of IIS signaling (Alessi et al., 1996).
Similarly, levels of Se which induce ROS formation prevent AKT
phosphorylation (Luo et al., 2012, 2013; Pinto et al., 2011; Wu et
al., 2006) or induce its dephosphorylation (Wu et al., 2006). By
preventing AKT activation, the downstream forkhead box O
transcription factors (FOXO) are not phosphorylated which leads
to their activation and subsequent nuclear translocation. Increased
incidences of metabolic disorders, including diabetes are associat-
ed with transcriptional activation of FOXO proteins (Barthel et al.,
2005). In addition, FOXO proteins are known to regulate expression
of pro-apoptotic and oxidative stress response genes (Eijkelen-
boom and Burgering, 2013) which inhibit cancers and aging
(Huang and Tindall, 2007) and their activation has also been shown
to be neuroprotective (Mojsilovic-Petrovic et al., 2009) and lead to
the transcription of SeP (Walter et al., 2008). A mutation in the
FOXA2 gene was also signiﬁcantly associated with the sporadic
form of the motor neuron disease, amyotrophic lateral sclerosis
(ALS) (Dunckley et al., 2007).
Environmental exposures to high levels of Se, have led to the
development of a neurological disorder in both humans and
animals that bears striking similarity to ALS (Vinceti et al., 2010;
Panter et al., 1996). More recently, Vinceti et al. (2013) reported
signiﬁcantly higher levels of Se(IV) in the cerebrospinal ﬂuid of
neurologically impaired patients that were later conﬁrmed to have
ALS. Additionally, they reported that SeP levels were reduced in
these patients. This coupled with the identiﬁcation of the FOXA2
association with sporadic ALS, as mentioned above implies that
FOXO transcriptional regulation may be altered in ALS. In fact, the
Caenorhabditis elegans FOXO3a ortholog, DAF-16 was shown to be
required for lifespan extension and improved movement by
reducing the toxic effects of TDP-43 (transactive response DNA
binding protein 43) and SOD1 (superoxide dismutase 1) (Boccitto
et al., 2012; Vaccaro et al., 2012; Zhang et al., 2011) which have
both been linked to sporadic and familial forms of ALS (Sreedharan
et al., 2008; Kabashi et al., 2008; Rosen et al., 1993; Jones et al.,
1993). The importance of FOXO in other neurodegenerative
diseases has been demonstrated in both C. elegans and elsewhere
(Wong et al., 2013; Parker et al., 2012; Maiese et al., 2007; Morley
et al., 2002).
The free-living soil nematode C. elegans has one selenoprotein, a
TrxR ortholog TRXR-1 (Gladyshev et al., 1999) which is not
required for Se-induced lethality (Boehler et al., 2013). Since
selenoproteins do not play a direct role in Se toxicity within C.
elegans, it is an ideal model to examine how Se alters other cellular
processes within a eukaryotic organism. The nervous system of C.
elegans hermaphrodites consists of 302 neurons and 56 supportcells, and contains all of the classic neurotransmitters observed in
higher organisms including serotonin, dopamine, acetylcholine, g-
aminobutyric acid (GABA), and glutamate (Altun and Hall, 2011).
Thus, C. elegans is an excellent model to study neurodegenerative
disease (Dimitriadi and Hart, 2010). We have shown previously
that in adult animals high dose exposures to Se in the form of
sodium selenite [Se(IV)] induce reactive oxygen species (ROS)
formation and motor neuron degeneration in C. elegans which
results in alterations in the normal movement behaviors leading to
paralysis and death (Estevez et al., 2012; Morgan et al., 2010).
These phenotypes could be partially ameliorated by exogenous
exposure to the cellular antioxidant reduced glutathione (GSH)
(Estevez et al., 2012; Morgan et al., 2010). Animals with mutations
in genes altering both cholinergic and GABAergic signaling were
more sensitive to Se(IV) [i.e. the mutations were shown to further
reduce normal movement in Se(IV) exposed animals], and reduced
cholinergic signaling across the neuromuscular junction (NMJ) was
determined to be partly responsible for these phenotypic changes
which mimics aspects of ALS pathology (Estevez et al., 2012). Here
we show that reductions in IIS signaling which lead to activation of
DAF-16/FOXO3a are neuroprotective against these Se(IV)-induced
effects. In addition we show evidence that Se(IV) causes
degeneration and loss of GABAergic motor neurons, and that the
loss of both the cholinergic and GABAergic neurons with high dose
Se(IV) exposure was partially dependent on the levels of DAF-16
expression within the animals. Here we also report that animals
with mutations in genes encoding for PTEN (phosphatase and
tensin homolog, deleted on chromosome 10) and PINK1 (PTEN-
induced putative kinase 1) are resistant to the positive improve-
ments on the Se(IV)-induced movement behaviors previously
observed with exogenous application of GSH. This GSH resistance
phenotype was only previously seen in animals with a mutation in
the dithiol glutaredoxin gene glrx-21 (Estevez et al., 2012; Morgan
et al., 2010). The model of Se(IV) toxicity presented here can be
used to further elucidate the link between increased Se status and
alterations in IIS signaling to disease processes affecting insulin
resistance and type 2 diabetes, and cancer, as well as neurodegen-
erative disorders such as ALS, Parkinson’s and Alzheimer’s
diseases.
2. Materials and methods
2.1. Strains, maintenance, and growth conditions
The following strains were used: N2: wild-type(WT) variety,
Bristol, CB1370: daf-2(e1370)III, CB1375: daf-18(e1375)IV, CB5600:
ccIs4251 [pSAK2 (Pmyo-3::GFP-LacZ(NLS)) + pSAK4 (Pmyo-3::mito-
chondrial GFP) + dpy-20(+)]I; him-8(e1489) IV, CF1038: daf-
16(mu86)I, CF1442: daf-16(mu86)I;daf-2(e1370)III; muEx169
[pNL206(Punc-119::gfp::daf-16a) + pRF4[rol-6(su1006)]], CF1514:
daf-16(mu86)I;daf-2(e1370)III; muEx211 [pNL213(Pges-1::gfp::daf-
16a) + pRF4 [rol-6(su1006)]], CF1515: daf-16(mu86)I;daf-2(e1370)-
III; muEx212 [pNL212(Pmyo-3::gfp::daf-16a) + pRF4[rol-6(su1006)]],
DR26: daf-16(m26)I, DR1564: daf-2(m41)III, GR1310: akt-
1(mg144)V, OM148: daf-2(e1370)III; yzIs71[Ptph-1::gfp + pRF4[rol-
6(su1006)]]V, OM249: daf-16(mu86)I; daf-2(e1370)III; yzIs71[Ptph-
1::gfp + pRF4[rol-6(su1006)]]V, OM261: vsIs33[dop-3::rfp]V; wuIs56-
[Psod-3::sod-3::gfp + pRF4[rol-6(su1006)]], OM285: daf-16(mu86)I;
yzIs71[Ptph-1::gfp + pRF4[rol-6(su1006)]], OM324: zIs356[pGP30(P-
daf-16::daf-16a2::gfp) + pRF4[rol-6(su1006)]]IV; vsIs33[Pdop-3::-
rfp]V, OM325 daf-16(mu86)I; vsIs33[Pdop-3::rfp]V; wdIs20[snb-
1::GFP], RB712: daf-18(ok480)IV, RB2547: pink-1(ok3538)II, TJ356:
zIs356[pGP30(Pdaf-16::daf-16a2::gfp) + pRF4[rol-6(su1006)]]IV,
TJ1052: age-1(hx546)II. The daf-16(mu86)I;daf-2(e1370)III animals
examined in Fig. 3A were obtained by selecting non-roller adult
animals from those strains expressing the daf-16-tissue speciﬁc
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expressing the extra-chromosomal array and were used as a control
for determining the effects of the double mutation on the Se(IV)-
induced motility deﬁcits.
The following caveat must be noted in regards to the sod-
3::GFP transgene used here. Expression of sod-3 accounts for only
1% of the total sod mRNA levels in C. elegans adults, thus the
strong expression exhibited by the sod-3::gfp transgene exam-
ined here is most likely artifactual, but as reported is very likely
to express the native pattern (Doonan et al., 2008). Several
laboratories have reported similar bright expression patterns
with the generation of other Psod-3 transgenes (Wolf et al., 2008;
Libina et al., 2003).
All strains were maintained and grown at 20 8C on modiﬁed
NGM plates without additional calcium as described (Estevez et al.,
2004) and all experiments were performed at 20 8C unless
otherwise stated.
2.2. Movement assay
Adult animals were developmentally synchronized and placed
on plates containing 5 mM sodium selenite (Spectrum Chemicals,
Gardena, CA) alone or with 3 mM glutathione (Sigma–Aldrich, St.
Louis, MO) as described (Estevez et al., 2012; Morgan et al., 2010).
Mock-exposed animals (controls) were placed on plates containing
an equivalent amount of carrier (dH2O) to that used on the
experimental plates. After plating, animals were scored at 24-h
intervals for the movement behaviors as previously described
(Morgan et al., 2010). For experiments performed at 25 8C,
developmentally synchronized animals at the fourth larval stage
(L4) were placed on plates overnight in order to develop to the
adult stage at 25 8C. They were transferred the next day to fresh
plates with or without the addition of Se(IV) as described (Morgan
et al., 2010). The percentage motile (%motile) indicates the number
of animals moving normally after a tap to the head and tail as
previously described (Morgan et al., 2010).
2.3. Heat-shock
Developmentally synchronized adult animals expressing the
Pdaf-16::gfp construct, zIs356 (Henderson and Johnson, 2001) were
placed on plates with 5 mM Se(IV) or an equivalent volume of
dH2O (mock-exposed control) for 2 h at 20 8C then shifted to 34 8C
for 30 min (Lin et al., 2001) before being ﬂuorescently imaged; or
they were directly visualized following the 2 h incubation.
2.4. Fluorescence imaging
Following either mock or Se(IV) exposure, ten live animals at a
time were anesthetized by placing them into a drop of M9/tricaine
solution (0.01% tricaine/0.001% tetramisole) on a glass microscope
slide. A coverslip was placed over the animals prior to visualiza-
tion. Three to ﬁve slides (30–50 animals) were visualized for each
experiment. Because the animals were visualized alive, only those
animals that remained alive and intact were documented.
Animals were visualized on an Olympus BX51 microscope
equipped with epiﬂuorescence (Olympus America Inc., Center
Valley, PA) and utilizing a FITC (GFP) or Texas Red (RFP) ﬁlter.
Images were documented with a QImaging Retiga 1300 camera
and imaging system (QImaging, Surrey, British Columbia,
Canada). Processing of images for publication was accomplished
by the Adobe CS5 Software package (Adobe Systems Inc., San Jose,
CA) utilizing both Photoshop and Illustrator to create the ﬁnal
images.
For the studies examining the effects of the proteasomal
inhibitors levamisole and the MG-132 (Z-Leu-Leu-Leu-CHO),CB5600 animals were simultaneously exposed to Se(IV) and either
of the drugs for 48 h. The concentrations of the drugs were as
described in Szewczyk et al. (2000).
2.5. Statistical analysis
Statistical analysis was performed by one-way ANOVA with
post hoc analysis by the Bonferroni–Holm method using Microsoft
Excel 2010 (Microsoft Inc., Seattle, WA) with the add-in Daniel’s XL
Toolbox version 5.6 (http://xltoolbox.sourceforge.net). Student’s t-
test was two-tailed with unequal variance.
3. Results
3.1. Mutations in the insulin/insulin-like growth factor pathway alter
sensitivity/resistance to environmental selenium
Populations of wild-type (WT) adult C. elegans animals exposed
to sodium selenite [Se(IV)] in their growth media exhibit a decline
in the percentage of normal moving animals that is both dose and
time dependent (Morgan et al., 2010). An exposure of 5 mM Se(IV)
was shown to lead to a progressive decline in movement from mild
impairment (backing deﬁcient) to paralysis, and death, and to
induce oxidative stress and cholinergic motor neuron degenera-
tion (Estevez et al., 2012; Morgan et al., 2010), all of which mimics
aspects of amyotrophic lateral sclerosis (ALS). ALS is a neurode-
generative disease characterized by motor neuron loss in the brain
and spinal cord and which typically results in death within ﬁve
years from diagnosis. The causes of ALS are multifaceted and
include both genetic factors, and environmental inﬂuences (Trojsi
et al., 2013). High dose Se exposures have been implicated in ALS-
like disease in both animals and humans (Vinceti et al., 2010).
Because alterations in insulin/insulin-like growth factor signaling
(IIS) have also been associated with ALS, we wanted to determine if
alterations in IIS signaling could affect the response of adult
animals in our high dose Se(IV) assay. To ﬁrst determine if
alterations in the levels of IIS signaling components can affect the
movement behavior of C. elegans adults, animals containing
mutations in genes encoding components of the IIS signaling
pathway were exposed over time to 5 mM Se(IV) and their
movement accessed. When grown at optimal growth temperature
(20 8C – Fig. 1A), animals with a reduction-of-function (rf)
mutation, m41 in the daf-2 gene which encodes for the C. elegans
insulin/insulin-like growth factor receptor (IGFR) (Kimura et al.,
1997), were more resistant to the Se(IV)-induced reduction in
normal motility at 72 h in comparison to WT (#, m41, Fig. 1A),
although at 24 h they were initially more sensitive (*, m41, Fig. 1A).
Both hx546 a rf mutation in the age-1 gene [which encodes for the
phosphoinositide 3-kinase (PI(3)K) (Morris et al., 1996) down-
stream of DAF-2 (Ogg et al., 1997)] and the rf mutation sa709 in the
worm PDK1 encoding gene pdk-1, conferred increased resistance to
the Se(IV)-induced motility impairment at 72 h (#, hx546, Fig. 1A;
data not shown for pdk-1, p = 2.2  103 by one-way ANOVA
comparing sa709 to WT at 72 h). In contrast, an activating mutation
in the gene encoding for the C. elegans ortholog of the serine/
threonine kinase AKT/PKB, akt-1(mg144) (Paradis and Ruvkun,
1998) and an rf mutation in the forkhead box transcription factor
(FOXO3a) gene, daf-16(m26) (Ogg et al., 1997; Lin et al., 1997)
signiﬁcantly increased the sensitivity of these animals to Se(IV) by
reducing the number of animals moving normally in comparison to
the WT strain (*, mg144 and m26, Fig. 1A). The increased sensitivity
to Se(IV) observed with these two strains was manifest across all
the time points tested. Thus, reductions in IIS signaling are
protective against the decline in normal movement behavior
previously observed to occur when WT adult animals were
exposed to high levels of environmental Se(IV).
Fig. 1. Mutations in the IGF pathway affect selenium sensitivity. Animals containing mutations in the daf-2 IGF pathway show an altered sensitivity to Se(IV)-induced motility
effects that is enhanced by increasing temperature. (A) When grown at 20 8C, adult animals were found to be more resistant (#) or to exhibit signiﬁcantly increased sensitivity
(*) to Se(IV) in comparison to the WT strain by one-way ANOVA performed across each time point (p  0.05; signiﬁcance was determined by post hoc analysis using the
Bonferroni–Holm method). (B) The phenotypes (sensitivity or resistance) observed at 20 8C were signiﬁcantly enhanced by Se(IV)-exposure at 25 8C at some or all of the time
points tested for all strains [^ signiﬁcantly different at 25 8 when each strain was compared to the same strain and time exposure at 20 8C; p < 0.05 by Student’s t-test (two
tailed, unequal variance)]. Comparisons of the mutant strains to WT when all were grown at 25 8C, showed signiﬁcant increases in resistance (#) or sensitivity (*) in the
animals at some or all of the time points tested. Analysis was by one-way ANOVA performed across each time point (p  1.4  1011; signiﬁcance was determined by post hoc
analysis using the Bonferroni–Holm method). When not exposed to Se(IV), all strains had 95% motility at each time point and temperature tested (data not shown), with the
only exception being akt-1 which exhibited 80% motility across all time points at 25 8C only (data not shown). Each bar graph represents the average of three populations
(n  150 at 20 8C; n  60 at 25 8C) with error bars indicating SEM. WT = N2 strain; Se = Se(IV). All mutations are reduction-of-function mutations with the exception of mg144
which is an activating mutation in the akt-1 gene.
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enhanced with increased temperature
Stressors including oxidative stress and heat can reduce IIS
signaling which leads to activation of DAF-16/FOXO3a (Landis and
Murphy, 2010; Honda and Honda, 2002). We have shown that high
dose Se(IV) exposures also result in increased stress as indicated by
the detection of reactive oxygen species (ROS) formation in
exposed animals and that increased temperature reduced move-
ment in WT animals (Morgan et al., 2010). To determine whether
the alterations in normal movement observed within populations
of the IIS mutant animals exposed to high dose Se(IV) could be
enhanced by increased temperature (i.e. increased stress), animals
grown at 20 8C until the adult stage were exposed to Se(IV) at 25 8C.
Many of the original components of the IIS signaling pathway were
isolated as temperature sensitive (ts) regulators of a developmen-
tal process that can lead to the formation of an alternate third stage
larva known as a dauer larva (Golden and Riddle, 1984; Riddle et
al., 1981; Swanson and Riddle, 1981; Riddle, 1977), and 25 8C is a
temperature at which the ts dauer larva formation phenotype is
fully penetrant in many of the IIS mutant strains (Swanson and
Riddle, 1981). At this higher temperature, the WT animals, those
with the rf mutations daf-2(m41) or daf-16(m26), or the akt-
1(mg144) activating mutation had signiﬁcantly fewer normal
moving animals at all of the time points when compared to animals
of the same genotype exposed at 20 8C for the given 24 h time
period (^, p < 0.05: Fig. 1B). Thus, there was an overall enhance-
ment of the sensitivity to the Se(IV)-induced effects on movement
when these animals were exposed at the higher temperature.
Similarly, the populations of age-1(hx546) animals were observed
to have a signiﬁcantly greater number of normal moving animals
within their populations, but only when they were exposed for48 h at 25 8C (^, p < 0.05: Fig. 1B). This was an enhancement of the
resistance phenotype observed at 48 h for the age-1(hx546)
animals exposed at 20 8C. Finally, when compared to the WT
strain exposed to Se(IV) at 25 8C, all of the IIS mutant strains
exposed under the same conditions exhibited the same Se(IV)
responsive phenotype that they exhibited at 20 8C [i.e. more
sensitive or resistant to Se(IV) in comparison to WT] with the
exception of akt-1(mg144) which was no different than WT at this
temperature (mg144, Fig. 1B). Thus, we show that the additional
stressor of increasing temperature during Se(IV)-exposure results
in enhancement of the Se(IV)-induced movement phenotypes that
were observed with exposures at 20 8C, and that high dose Se(IV)-
exposure induces a stress response process that appears to be
mediated by IIS signaling similar to its control of other stress
response pathways (Shore and Ruvkun, 2013).
3.3. daf-2 alleles have opposite selenium responsive phenotypes
under high temperature stress
There are over 40 daf-2 alleles that have been isolated and these
have been described to express a range of phenotypes in response
to environmental and oxidative stressors (Ackerman and Gems,
2012; Honda and Honda, 2002; Scott et al., 2002; Gems et al.,
1998). Most recently, Vaccaro et al. (2012) showed that the e1370
allele enhanced neurodegeneration in a worm TDP43/TDP-1 ALS
model while another allele e1368 suppressed the neurodegenera-
tion. The m41 allele has been previously described as thermolabile
or a true temperature-sensitive allele (Gems et al., 1998) and has
demonstrated differences in phenotype from the hypomorphic
alleles of daf-2 in regards to life span, intrinsic thermal tolerance,
and enhancements of its Daf-c phenotype by mutations in the
tyrosine phosphatase-like sdf-9 (Gems et al., 1998; Jensen et al.,
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sensitive to the Se(IV)-induced effects on normal movement when
exposed at 25 8C, a phenotype it shared with the daf-16(m26)
animals (Fig. 1B). Yet, at 20 8C although it was also initially more
sensitive, after 72 h of exposure time the daf-2(m41) animals were
more resistant to Se(IV)’s effect on normal movement; a phenotype
opposite to that of the daf-16 mutant animals exposed under the
same conditions (Fig. 1A). Because of this discrepancy in
phenotypes exhibited by the m41 allele after Se(IV)-exposure,
we tested an additional allele e1370 for its effect on movement
behavior during the combined Se(IV) and heat-induced stress
conditions. The e1370 allele was previously shown to be more
resistant to the combined effects of oxidative stress and hyperoxia,
a phenotype that was opposite to and suppressed by a mutation in
the daf-16 gene (Honda and Honda, 2002). Here we similarly
observed that the daf-2(e1370) animals were signiﬁcantly and
consistently more resistant to the Se(IV)-induced reductions in
normal movement when compared to WT animals grown under
the same conditions at 25 8C (#, e1370, Fig. 1B). Because the
combined stressors of high heat and high dose Se(IV) exposure
enhanced the phenotypes of the other IIS signaling component
mutants, it is very likely that the phenotype expressed by the daf-
2(e1370) allele under these conditions is more indicative of the
phenotype that other daf-2 alleles (other than m41) would be
expected to express.
3.4. Selenium induces nuclear translocation of DAF-16/FOXO3a
DAF-16 has been observed to translocate into the nucleus in
response to starvation, heat shock, and oxidative stressors
(Henderson and Johnson, 2001; Lin et al., 2001). Here we have
shown that reduction in IIS signaling coupled with high dose Se(IV)
exposure reduces the percentage of normal moving animals and
that this can be enhanced when exposure occurs at an increased
temperature. Since reduction in IIS signaling can activate DAF-16
and reduction of daf-16 function leads to increased Se(IV)-
sensitivity (Fig. 1), we hypothesized that high dose Se(IV) exposure
would lead to nuclear translocation of DAF-16. In order to
investigate this, we examined a strain TJ356 that overexpresses
the DAF-16a2 isoform linked to the green ﬂuorescent protein (GFP)
and which is driven by the daf-16 promoter (Henderson and
Johnson, 2001). Under normal growth conditions (well-fed and
grown at 20 8C) expression of this DAF-16::GFP reporter is diffuse
and primarily localized to the cytoplasm (Fig. 2A), as was reported
previously (Henderson and Johnson, 2001). Translocation of the
DAF-16::GFP to the nucleus occurs with mild heat shock (34 8C for
30 min) (Henderson and Johnson, 2001; Lin et al., 2001). It was
observed here that mild heat shock was capable of inducing
nuclear translocation in adults as evidenced by the localized
punctate expression of the GFP although some cytoplasmic
localization was still observed (Fig. 2B). Our previous studies
had shown that exposures to high dose Se(IV) could induce
phenotypic changes in the normal movement and egg-laying
behaviors of adult animals in as early as 6 h (Estevez et al., 2012;
Morgan et al., 2010). Here we observed translocation of DAF-
16::GFP to the nucleus within only 2 h after exposure to Se(IV)
although cytoplasmic localization was still apparent (Fig. 2C).
Henderson and Johnson (2001) similarly showed that the
localization of DAF-16::GFP after exposure to the pro-oxidant
juglone was not as strong as when animals were exposed to heat
shock. Since we had shown that in WT animals coupling Se(IV)
exposure with increased temperature could enhance the Se(IV)-
induced reduction in normal movement (Fig. 1B; Morgan et al.,
2010), we expected that exposing animals to Se(IV) for 2 h
followed by mild heat shock would enhance the nuclear
localization of DAF-16. As expected, when the 2 h Se(IV) exposurewas followed by heat shock, the majority of the DAF-16 expression
was observed to be located in the nucleus (Fig. 2D). This nuclear
localization was stronger than when animals were exposed to mild
heat shock (Fig. 2B) or Se(IV) alone (Fig. 2C). Thus, as predicted
exposure to high dose Se(IV) levels lead to activation of DAF-16
similar to that previously observed to occur with reductions in IIS
signaling. This activation could be enhanced by the additional
stress of high temperature exposure as was observed for the
movement behaviors.
3.5. DAF-16 is required to alleviate the selenium induced effects on
normal movement
WT adult animals chronically exposed to high dose Se(IV) levels
experienced behavioral deﬁcits that increased with the time of
exposure (Estevez et al., 2012; Morgan et al., 2010). Similarly, it
was shown here that the percentage of normal moving animals
continued to decrease over time when Se(IV)-exposure was
coupled with IIS signaling reduction (Fig. 1A). Thus, it was
expected that increasing the time of exposure to high dose Se(IV)
would also increase the number of cells with activated DAF-16 that
was localized to the nucleus. This was not the case. Instead
increasing the exposure time to 24 (Fig. 2E) or 72 h (Fig. 2F) did not
alter the expression pattern from that observed after the 2 h Se(IV)
only exposure (Fig. 2C). One possible explanation for this
unexpected result is that with continued exposure to Se(IV), a
greater percentage of animals die or are signiﬁcantly impaired
(Morgan et al., 2010), thus only animals that are experiencing less
Se(IV)-induced stress are able to survive the photo-documentation
process. To circumvent this issue we examined the effect of high
dose Se(IV)-exposure over time on animals experiencing different
levels of DAF-16 expression and examined their motility (Fig. 2G).
daf-16(mu86) is a deletion allele that is a presumptive null
mutation (Lin et al., 1997). Animals with this mutation were
signiﬁcantly more sensitive to the effects of Se(IV) on movement
than the animals with WT levels of DAF-16 at both 24 h and 72 h
after Se(IV) exposure (*, Fig. 2G; Table 1). This was similar to the
levels observed with the daf-16 rf allele, m26 (Fig. 1A). Thus, loss of
DAF-16 leads to a predicted sensitivity to high dose Se(IV). In
contrast, overexpression of DAF-16 [daf-16(o/e)] improves motility
over time since signiﬁcantly more animals are moving normally
within this population than in populations of animals with WT
levels of DAF-16 at the 72 h exposure time point (#, Fig. 2G). Thus,
increasing the expression level of DAF-16 is capable of minimizing
the Se(IV)-induced declines in normal movement observed over
time with Se(IV)-exposure.
3.6. Tissue-speciﬁc expression of DAF-16 partially rescues the daf-16-
deﬁcient selenium sensitivity
DAF-16 is natively expressed in all tissue types except some
pharyngeal cells (Henderson and Johnson, 2001). The prior
experiment demonstrated that overexpression of DAF-16 in native
tissue is capable of partially alleviating the Se(IV)-induced effects
on motility (Fig. 2G), but could not address which speciﬁc tissue, if
any DAF-16 was exerting this effect. Previous studies showed that
expression of DAF-16 in intestines could partially restore the
reduced lifespan of daf-16(-) animals (Libina et al., 2003).
To determine whether expression of DAF-16 in speciﬁc tissues
was capable of improving the movement of animals exposed to
high dose Se(IV), we took advantage of the availability of strains
CF1442, CF1514, and CF1515 (Table 1 and Section 2.1) which
express GFP::DAF-16 under control of promoters for the nervous
system (muEx169), intestines (muEx211), and muscles (muEx212),
respectively (Libina et al., 2003). All of these strains were
constructed to have the same genetic background and include
Fig. 2. DAF-16 nuclear localization and dosage effects on motility with selenium exposure. Se(IV) induces DAF-16::GFP to translocate to the nucleus which is required for
protection from the Se(IV)-induced effects on motility. (A–F) A strain (TJ356) containing a transgene (zIs356) that overexpresses wild-type DAF-16::GFP under control of the
daf-16 promoter (Henderson and Johnson, 2001) was examined to determine its subcellular localization under various conditions. (A) Well-fed animals maintained at 20 8C
show cytoplasmic expression of DAF-16::GFP. (B) Heat-shock-induced stress results in nuclear localization of DAF-16 (indicated by arrows) as previously described
(Henderson and Johnson, 2001; Lin et al., 2001). (C) Se(IV) exposure induced DAF-16::GFP translocation after 2 h. (D) Exposure to Se(IV) for 2 h followed by heat shock
increased nuclear translocation. (E and F) Longer exposures to Se(IV) (without heat shock) did not vastly increase localized GFP expression. All animals were maintained in a
well-fed state at 20 8C and were exposed in the presence of food. Magniﬁcation = 100. (G) In comparison to the WT strain, the presumptive null-mutation, daf-16(mu86)
conferred signiﬁcantly more sensitivity to the Se(IV)-induced effects on motility at 24 and 72 h [*, sensitivity to Se(IV), p  8.0  103] while animals overexpressing DAF-16
[daf-16(o/e) = zIs356] were signiﬁcantly more resistant at 72 h [# resistance to Se(IV); p = 4.3  106] by one-way ANOVA performed across each time point with signiﬁcance
determined by post hoc analysis using the Bonferroni–Holm method. Each graph bar represents at least three populations of 20 animals per strain (n  60); error bars indicate
SEM. Se = Se(IV).
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mu86 mutation presumably eliminates any native DAF-16
expression since it is believed to be a null mutation in the daf-
16 gene (discussed in Section 3.5). Thus, DAF-16 expression in each
of these strains would be limited to the speciﬁc tissues controlled
by the promoter regulating its expression. In addition, each of the
transgenes also contain a reporter plasmid pRF4 expressing the
mutation su1006, an allele of a collagen gene rol-6 which results in
a dominant rolling (Rol) phenotype in the animals that express this
mutation. Rolling movement is different than normal sinusoidal
movement therefore we had to conﬁrm that the Rol phenotype had
no effect on the Se(IV)-induced movement deﬁcits. To accomplish
this we generated a strain (OM249; Section 2.1) that expresses a
different transgene (yzIs71), but contains the same reporter
plasmid pRF4, and is in the same genetic background daf-
16(mu86);daf-2(e1370) as the strains expressing the tissue speciﬁctransgenes (Roller control: daf-16;daf-2;yzIs71; Fig. 3A). When
compared to daf-16(mu86);daf-2(e1370) animals containing no
transgene (Non-roller control; Fig. 3A), the OM249 animals (Roller
control: daf-16;daf-2;yzIs71; Fig. 3A) were not signiﬁcantly
different (NS; Fig. 3A) over all the time points tested. In addition,
there was also no difference between OM249 and OM285 (Section
2.1) a strain that was identical to OM249, but lacking the daf-2
mutation (Roller control: daf-16;yzIs71; Fig. 3A). These data
suggest that the Rol phenotype did not affect the Se(IV)-induced
movement deﬁcits.
Next animals from each of the three tissue speciﬁc DAF-16
expression strains (CF1442, CF1514, CF1515; Rollers with tissue
speciﬁc DAF-16::GFP expression: Fig. 3A; Table 1) were exposed to
Se(IV) and compared at all the time points to both OM249 (Roller
control: daf-16;daf-2;yzIs71; Fig. 3A) and the daf-16;daf-2 animals
expressing no transgene (Non-roller control; Fig. 3A). All of the
Table 1





Transgene Phenotype Time (h) Mean







N2 WT None Non-roller 24 65.5  5.5 – – –
48 42.8.0  6.5 – – –
72 32.0.0  3.5 – – –
CB1370 daf-2 (e1370) None 24 97.0  1.2 – – –
48 94.0  1.0 – – –
72 89.0  2.4 – – –
CF1038 daf-16 (mu86) None 24 39.6  5.2 – – –
48 23.8  3.2 – – –
72 6.1  1.9 – – –
Nonec daf-16;daf-2 None 24 24.0  5.8 – 1.7  106 NS
48 11.0  4.8 – 1.6  107 NS
72 1.0  1.0 – 7.3  1010 NS
TJ356 WT zIs356 (native) Roller 24 55.3  2.0 NS – –
48 56.3  11.8 NS – –
72 67.7  4.8 1.5  106 – –
CF1442 daf-16;daf-2 muEx169 (nerve) 24 53.1  6.8 0.01 4.2  104 NS
48 35.0  7.0 NS# 4.3  105 NS
72 23.1  4.6 3.6  103 4.3  107 3.6  104
CF1514 muEx211 (intestine) 24 90.0  2.0 1.7  108 NS 1.3  107
48 38.3  6.4 0.01 3.7  105 NS
72 19.4  4.5 0.01 1.5  1010 3.0  103
CF1515 muEx212 (muscle) 24 68.9  2.9 4.5  106 1.4  105 1.4  104
48 13.3  3.3 NS# 6.6  1010 NS
72 5.6  2.3 NS 2.3  1011 NS
a NS = not signiﬁcant (p > 0.01) as determined by one-way ANOVA with post hoc testing by the Bonferroni–Holm method. p-Values were for strain comparisons at the same
time (h).
b Non-transgene = the strain with the same genetic background as the strain that it is being compared to, but this strain differs because it does not express a transgene; e.g.
TJ356 animals were compared to N2 since both strain have a WT genetic background, but TJ356 contains a transgene while N2 does not.
c The daf-16;daf-2 animals used here were obtained by selecting non-roller adult animals from those strains expressing the daf-16-tissue speciﬁc extra-chromosomal
arrays (CF1442, CF1514, CF1515). Animals that did not roll were no longer expressing the extra-chromosomal array and were used as a control for determining the effects of
the double mutation on the Se(IV)-induced motility deﬁcits.
# p  0.01when compared to the roller control strain (daf-16;daf-2;yzIs71; Fig. 3A, ‘‘#’’).
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cant improvement when compared to OM249 (#, Fig. 3A) as well as
to the daf-16;daf-2 non-roller control animals (Table 1), but with a
few exceptions (NS, p value against non-transgene, Table 1). The
most notable improvement was observed at the 24 h exposure
time point in animals expressing DAF-16 in the intestines (CF1514:
Table 1). When the CF1514 animals were compared to either the
daf-2 non-roller (CB1370, Table 1) or daf-2 roller animals (Roller
control: daf-2;yzIs71; Fig. 3A), the CF1514 animals were not
signiﬁcantly different (NS; Table 1 and Fig. 3A). Both of these daf-2
strains exhibit the Se(IV)-resistance phenotype previously ob-
served for the daf-2(e1370) allele (Fig. 1B) and do not have a
mutation in the daf-16 gene, thus they express WT levels of DAF-
16. This demonstrates that the Se(IV)-induced movement deﬁcits
observed in animals lacking DAF-16 could be fully suppressed at
24 h by intestinal expression of DAF-16 in a daf-16;daf-2 mutant
background. After 24 h, intestinal suppression was still signiﬁ-
cantly improved, but the percentage of normal moving animals
within the population trended downward (Fig. 3A). This trend
downward was observed over time for all three of the DAF-16
tissue speciﬁc strains when exposed to Se(IV) and with the
exception of the 72 h muscle speciﬁc expression, they all still
maintained a signiﬁcant improvement over the daf-16;daf-2 non-
roller and roller control strains, (Fig. 3A and Table 1). Thus,
expression of DAF-16 in the nerves, intestines, or muscles is
capable of at least partially preventing the Se(IV)-induced effects
on movement with the greatest improvement observed in the
intestines at 24 h.
3.7. Selenium cause mitochondrial damage to muscles
Muscle damage after exposure to high levels of Se is well
documented in livestock and humans (Davis et al., 2012; Spillerand Pﬁefer, 2007; Tiwary et al., 2006), but in C. elegans the body
wall and egg-laying muscles were shown to be functionally and
structurally intact after 48 h of exposure to high dose Se(IV)
(Estevez et al., 2012). Yet, here we have demonstrated that muscle
speciﬁc expression of DAF-16 can lead to partial rescue of normal
movement (Fig. 3A) suggesting that Se(IV) does affect muscle in C.
elegans. Recent studies have shown that activation of FOXO3a
leads to ROS accumulation in the mitochondrial membrane which
is followed by additional accumulation of FOXO3a in the nucleus
and later more intense mitochondrial ROS accumulation culmi-
nating in apoptosis (Hagenbuchner and Ausserlechner, 2013). If a
similar cascade of events is occurring in the muscle after Se(IV)
exposure than it is possible that the reduction in normal
movement observed after the 48 h time point in animals with
DAF-16 muscle speciﬁc expression may be due to the accumula-
tion of mitochondrial damage. To examine this possibility, we
used a strain CB5600 which expresses GFP in the mitochondria
and nuclei of muscle and exposed the animals for 48 h to Se(IV)
(Fig. 3B). Since after the 48 h time point Se(IV)-exposed animals
experienced increased lethality and fragility, it was not possible to
examine these older animals. At 48 h, the mitochondria of the
water treated age-matched controls exhibited normal tubular
shaped expression (H2O, Fig. 3B) while the GFP expression of the
mitochondria in Se(IV) exposed animals was observed to be
patchy and disorganized an indication that fragmentation of the
mitochondrial network had occurred (Se, Fig. 3B). Although
levamisole and MG-132 (Z-Leu-Leu-Leu-CHO) have been shown
to block proteasome mediated degradation in muscle (Mun˜oz-
Lobato et al., 2013; Estevez et al., 2012), they were not able to here
block the Se(IV)-induced mitochondrial fragmentation (Supp. Fig.
1). These data demonstrate that Se(IV) exposure is capable of
inducing mitochondrial damage to muscle and that this damage is
not prevented by proteasomal blockade.
Fig. 3. Selenium exposure and the effects of tissue-speciﬁc expression of DAF-16 on motility. Overexpression of DAF-16 in nerves, intestines, or muscles of adult animals
resulted in an increased resistance to the Se(IV)-induced motility defects. (A) Animals expressing the DAF-16 tissue-speciﬁc constructs were more resistant (#) to the Se(IV)-
induced effects on motility when compared to animals with the same genetic background (daf-16;daf-2) and that expressed the same reporter plasmid, pRF4. This plasmid
contained within the yzIs71 transgene induces animals to roll in place (roller phenotype) rather than move forward or backward in a normal sinusoidal wave pattern, a
phenotype that results from the expression of a dominant mutation (su1006) in the rol-6 gene (Mello et al., 1991). No signiﬁcant difference (NS) was observed between the
daf-16;daf-2 roller and non-roller strains at all temperatures, between the daf-16 and the daf-16;daf-2 roller strains at all temperatures, nor the daf-2 roller strain and the daf-
16;daf-2 intestine expressing strain at 24 h only (as determined by one-way ANOVA). Signiﬁcance is deﬁned as p  0.01 as determined by one-way ANOVA followed by post
hoc analysis using the Bonferroni–Holm method. All non-Se(IV)-treated strains had a greater than 90% survival at all times tested (data not shown). Each bar graph represents
the average of six populations of 20 animals per strain (n = 120); error bars  SEM. daf-16 = daf-16(mu86); daf-2 = daf-2(e1370); daf-16;daf-2;yzIs71 = OM249; daf-
16;yzIs71 = OM285; daf-2;yzIs71 = OM148. (B) Upper panel: Animals of the strain CB5600 transiently express mitochondrial GFP in their muscles and are shown here after 48 h of
either mock- (dH2O) or Se(IV)-(Se)exposure. The GFP pattern is tubular indicating healthy mitochondria in the water control (dH2O). Se(IV)-exposure results in fragmentation of the
GFP expression indicating damage to the muscle mitochondria (Se). Lower panel: Black and white outline of GFP expression patterns above, nuclei are represented by asterisks for
orientation. Se = Se(IV).
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Because expression of DAF-16 in neurons partially rescued the
Se(IV)-sensitivity phenotype of daf-16(mu86), we examined
whether this partial rescue was due to activation of DAF-16 in
the motor neurons speciﬁcally. In animals expressing vsIs33,
cholinergic motor neurons weakly express RFP making them easily
identiﬁable from the GABAergic motor neurons which strongly
express RFP under control of the promoter for the dop-3 gene
which encodes for the C. elegans ortholog of the mammalian D2
dopamine receptor (Chase et al., 2004). In animals expressing dop-
3::rfp in a WT daf-16 background [daf-16(+); Fig. 4A], Se(IV)-
exposure induced the cholinergic motor neurons (small arrows,
Fig. 4) to round and lose their fusiform shape, and blebbing of the
ventral cord (white lines, Fig. 4A), as had been previously described
(Estevez et al., 2012). Reduction in GABAergic signaling through
the UNC-49 receptor was shown to decrease the percentage of
forward moving animals after Se(IV)-exposure (Estevez et al.,2012) and here we show that the GABAergic motor neurons (large
arrows, Fig. 4) showed signs of neurodegeneration similar to that
observed in the cholinergic motor neurons (small arrows, Fig. 4).
Loss of DAF-16 [daf-16(-); Fig. 4A] seemed to enhance these Se(IV)
induced effects. The over-expression of DAF-16 [daf-16(o/e); Fig.
4A] under control of the daf-16 promoter was partially protective
against these changes since axonal blebbing was reduced, as was
cell-rounding although evidence of cell loss was still apparent (x,
Fig. 4A). Cytoplasmic and nuclear localization of DAF-16::GFP has
been reported in the neurons of daf-16(+) animals grown under
standard conditions (Henderson and Johnson, 2001) and speciﬁ-
cally in the ventral cord neurons of dauer larvae (Lin et al., 2001). In
the animals overexpressing DAF-16, the protein did not appear to
be localized to the nucleus in the motor neuron cells (compare
dH2O and Se, Fig. 4B), but was expressed in the nuclei of muscle
cells (M, Fig. 4B) after Se(IV) exposure. Together, these data
demonstrate that although Se(IV) does not cause detectable
nuclear translocation of the DAF-16::GFP within motor neurons,
Fig. 4. Selenium exposure and the dosage effects of DAF-16 on neurodegeneration. The level of DAF-16 expression affects the observed levels of neurodegeneration in the
ventral cord. (A) The DOP-3::RFP construct (vsIs33) expresses in both cholinergic (small arrows) and GABAergic (large arrows) motor neurons, but more weakly expresses in
the former than the latter (Chase et al., 2004). In animals with WT levels of DAF-16 [daf16(+) = strain OM261], the normal fusiform shape of the motor neuron cell bodies
observed in the control animals [daf-16(+), dH2O] is altered in animals exposed to Se(IV) [daf-16(+), Se]. Axonal blebbing of the ventral cord (line) is also observed with Se(IV)
exposure, but not in the control animals; as was previously reported (Estevez et al., 2012). With loss of DAF-16 [daf-16(-) = strain OM325], neuronal damage is increased.
Over-expression of DAF-16 [daf-16(o/e) = strain OM324] reduced the blebbing in the cord as well as cell body rounding. Cell loss was still observed in the DAF-16 over-
expressing animals. This had been shown previously to occur in WT animals exposed to Se(IV) (Estevez et al., 2012). (B) Se(IV) does not induce DAF-16::GFP (zIs356)
localization to the nucleus in either the cholinergic (small arrows) or GABAergic motor neurons (large arrows) of adult animals (strain = OM324), but was observed in muscle
cells (M). Nuclear localization of DAF-16 in the hypodermal cells (H) of animals not exposed to Se(IV) (dH2O) is most likely due to stress induced on the animals which were
alive, but paralyzed while being imaged, as previously observed (Lin et al., 2001). Magniﬁcation = 400. Se = Se(IV). The genotype of each strain is listed in Section 2. Animals
shown here are representative of 30–50 animals examined under.
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can be ameliorated by increased global expression of DAF-16.
3.9. Mutation in the DAF-16 target gene sod-3 leads to selenium-
resistance
The superoxide dismutases (SOD) are required for oxidative
stress responses in many organisms including C. elegans (Honda
et al., 2010; Doonan et al., 2008). There are three general types of
SOD: copper/zinc (Cu/Zn SOD or SOD1), manganese (Mn-SOD or
SOD2), and extracellular (EC-SOD or SOD3) (Miao and St Clair,
2009). Deletion of SOD2 in mice leads to progressive motor
weakness and neurodegeneration (Lebovitz et al., 1996). In
addition, SOD2 has been implicated in mitochondrial dysfunction
and examined for its role in models of neurodegenerative diseases
including stroke, ALS, and Parkinson’s, Alzheimer’s, and Hunting-
ton’s Diseases (Flynn and Melov, 2013; Maier and Chan, 2002;
Andreassen et al., 2000). In C. elegans, there are two Mn-SODs
encoded by the sod-2 and sod-3 genes (Hunter et al., 1997) which
have been shown to be transcriptionally regulated by DAF-16
(Cabreiro et al., 2011; Oh et al., 2006). Knockout/reduction
mutations in the sod-3 gene typically have no effect or are
sensitivity to oxidative stressors such as paraquat and juglone
(Back et al., 2012), but have been shown to be more resistant to
cadmium toxicity (Roh et al., 2009); similar results have been
reported for sod-2 mutations in regards to stress (Back et al., 2012).
When exposed to high dose Se(IV), animals with a mutation in sod-
2 were more sensitive after 24 h of exposure in comparison
to WT animals (p = 3.8  103, Fig. 5A, *) while those with a
mutation in sod-3 exhibited resistance across all time points tested
(p  0.02; Fig. 5A, #) with regards to their movement phenotype.The Se(IV)-resistance exhibited by the sod-3 mutant animals was
suppressed by the sod-2 mutation in sod-2;sod-3 double mutant
animals, and the double mutant strain was more sensitive to Se(IV)
than was sod-2 alone (p = 4.2  104, compared at the 24 h time
point; Fig. 5A). Increased sensitivity for sod-2;sod-3 double mutant
animals was previously reported for stress induced by paraquat-
hyperoxia and juglone treatments (Back et al., 2012). Thus, loss of
sod-3 or sod-2 had opposite phenotypes in regards to their
response to high dose Se(IV)-exposure while the sod-2;sod-3
double mutant exhibited a phenotype similar to the sod-2
mutation alone.
Since animals with loss of SOD-3 expression are resistant to the
movement deﬁcits normally elicited by high dose Se(IV) exposure,
we hypothesized that SOD-3 overexpression would not protect
motor neurons from Se-induced neurodegeneration. To determine
this we examined the ventral cord of animals overexpressing SOD-
3 translationally fused to GFP (Fig. 5B). These animals coexpressed
the dop-3::rfp transgene examined previously (Fig. 4) allowing for
ease in identifying the GABAergic (large arrows, Fig. 5B) and
cholinergic (small arrows, Fig. 5B) motor neurons. SOD-3::GFP
expression was observed in both types of motor neurons and along
the ventral cord in the mock-exposed animals (dH2O, Fig. 5B). After
24 h of exposure to Se(IV), the SOD-3::GFP expression pattern
appeared fragmented within the motor neurons (Se, Fig. 5B, larger
images and smaller panels to the right). Since SOD-3 was shown to
co-localize with mitochondrial staining (Wolf et al., 2008), this
fragmentation pattern most likely reﬂects mitochondrial fragmen-
tation similar to that observed in the muscle (Fig. 3B). In addition,
signs of degeneration including rounding of the motor neurons and
blebbing of the ventral cord were observed with Se(IV) exposure
(Se, Fig. 5B). Thus, as predicted by the loss-of-function sod-3
Fig. 5. The effects of mutations on downstream target genes of DAF-16 transcription. C. elegans encodes for two superoxide dismutase 2 (SOD2) genes which are regulated by
DAF-16 and have opposite effects on the Se(IV)-induced movement deﬁcits. (A) Animals with a mutation in the sod-2 gene are initially more sensitive to the effects of Se(IV)
than WT animals (at 24 h: p = 3.8  103 by one-way ANOVA), but at later time points are no different than WT animals (p  0.5) while animals with a sod-3 mutation are
consistently and signiﬁcantly more resistant to Se(IV)’s effect on movement than WT (p  0.03 by one-way ANOVA across all time points tested). The sod-2;sod-3 double
mutant animals are phenotypically similar to the sod-2 single mutant animals, the animals are initially more sensitive than WT to Se(IV) at 24 h (p = 4.3  104 by one-way
ANOVA), but are no different at the later time points (p > 0.1). Animals were grown at 25 8C, but the trends and signiﬁcances were the same for animals grown at 20 8C (data
not shown). (B) Animals of the strain OM261 which expresses DOP-3::RFP and over-expresses a SOD-3::GFP translational fusion under control of its native promoter (wuIs56)
were exposed to either water (dH2O) or Se(IV) (Se) for 24 h. The SOD-3::GFP was observed to co-localize with DOP-3::RFP to the ventral cord and the motor neurons (large
arrows = GABAergic; small = cholinergic), but was unable to protect either from the Se(IV)-induced neurodegenerative effects. This SOD-3::GFP expression is discontinuous in
the Se(IV)-exposed motor neurons (Se, SOD-3::GFP, right panels) in comparison to the water exposed ones (H2O, SOD-3::GFP, right panel) suggesting that mitochondrial
fragmentation has occurred as was observed in the Se(IV)-exposed muscle (Fig. 3B). In the Se(IV) exposed animals, muscles are observed to exhibit increased expression of
DOP-3::RFP that did not colocalize with the SOD-3::GFP expression (Se, white outline) and was not observed in the water controls. Smaller panels on the right focus in on the
motor neurons that are boxed in the larger image immediately to their left. Magniﬁcation = 400. Se = Se(IV).
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generation previously observed to occur in the GABAergic (Fig. 4)
and cholinergic (Fig. 4; Estevez et al., 2012) motor neurons after
high dose Se(IV)-exposure.
3.10. Selenium exposure increases expression of the DOP-3/D2
dopamine receptor in muscle
Muscles expressing the DOP-3::RFP and exposed to Se(IV),
showed increased expression levels of DOP-3::RFP not observed in
the muscles of water exposed animals (Fig. 5B; compare DOP-
3::RFP, dH2O to Se). This expression did not appear to co-localizewith the SOD-3::GFP expression [Fig. 5B, outlined regions in
Se(IV)-exposed animals]. Expression of DOP-3::RFP in muscles has
been previously reported as weak (Chase et al., 2004). No previous
studies to our knowledge have described DOP-3 expression
patterns in muscles under stress. Here we demonstrate that stress
induced by high dose Se(IV) exposure increased expression of DOP-
3 in the muscle.
3.11. Deletion of daf-18/PTEN leads to selenium sensitivity
Mutations in PTEN (phosphatase and tensin homolog deleted
on chromosome 10) and PINK1 (PTEN-induced putative kinase 1)
Fig. 6. The cellular antioxidant glutathione and its effect on modulators and a downstream regulator of IGF signaling when exposed to selenium. Animals containing
mutations in the genes encoding the C. elegans orthologs of PTEN (phosphatase and tensin homolog, daf-18) and PINK1 (PTEN-induced putative kinase, pink-1), modulators of
the IGFR signaling are not rescued from the Se(IV)-induced motility defects by exposure to the cellular antioxidant glutathione (GSH), but the Se(IV)-sensitivity observed with
the daf-16(mu86) mutation was rescued. All the strains were sensitive to Se(IV), but increased sensitivity to Se(IV) (*, p  0.05) was not observed until 24 h of exposure in the
animals with a mutation in daf-16, and at 72 h in the daf-16 and daf-18(e1375 and ok480) mutant animals when compared to wild-type (WT). Analysis was by one-way ANOVA
performed across each time point [signiﬁcance (indicated above bar graphs) was determined by post hoc analysis using the Bonferroni–Holm method; NS = not signiﬁcant].
Glutathione was able to signiﬁcantly rescue the Se(IV)-induced deﬁcits in WT animals after 72 h of continuous exposure (signiﬁcance is indicated above each pair of bars and
was determined by Student’s t-test). When not exposed to Se(IV), all strains had 95% motility at each time point and temperature tested (data not shown). The addition of
GSH [without Se(IV)] did not alter motility in comparison to the control (water only exposed) animals (data not shown). Each bar graph represents the average of three
populations (n  60) with error bars indicating SEM. Se = Se(IV).
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ALS, Parkinson’s and Alzheimer’s Diseases (Domanskyi et al., 2011;
Kirby et al., 2011; Wilhelmus et al., 2011; Morimoto et al., 2010;
Sonoda et al., 2010; Valente et al., 2004). PTEN has been shown to
regulate neuronal outgrowth and induces apoptotic cell death in
neurons (Wong et al., 2013; Christensen et al., 2011) by inhibiting
PI(3)K-dependent activation of AKT (Stambolic et al., 1998)
allowing for the activation of FOXO transcription. Conversely,
PINK1 is required for the IIS dependent activation of AKT (Akundi
et al., 2012) which leads to the phosphorylation inactivation of
FOXO. Because of their opposite roles in regulating FOXO
transcription, we hypothesized that mutations in the C. elegans
orthologs of PTEN and PINK1, daf-18 and pink-1, respectively, would
have opposite phenotypes in regards to their responsiveness to
high dose Se(IV) exposure: daf-18/PTEN mutants would be
expected to express a sensitivity phenotype similar to that
observed with loss or reduction of daf-16 while PINK1 mutants
should be more resistant to Se(IV). As expected, animals with the
daf-18 mutations e1375(rf) and ok480(lf) were both more sensitive
although this sensitivity was not observed until 72 h after
exposure to high dose Se(IV) (*, Fig. 6). This sensitivity phenotype
was similar to previous studies in which it was demonstrated that
genetic or RNA inhibition of daf-18 resulted in increased sensitivity
to the oxidative stressor paraquat (Masse et al., 2008; Honda and
Honda, 2002). Animals with a mutation in the pink-1(ok3538) were
no more sensitive or resistant to Se(IV) than was WT (Fig. 6). Thus,
although PINK-1 does not appear to be required for Se(IV) to induce
its neurotoxic effects on movement in C. elegans, loss of daf-18 doesincrease sensitivity to Se(IV) suggesting that it plays a protective
role against Se(IV)-induced toxicity.
3.12. Glutathione requires DAF-18 and PINK-1 to ameliorate the
selenium-induced movement deﬁcits
The cellular antioxidant reduced glutathione (GSH) plays an
essential role in protecting against the damaging effects ROS. In C.
elegans, exogenous GSH has been shown to reduce oxidative stress
and to partially rescue the movement and egg-laying deﬁcits
caused by Se(IV)-exposure in WT animals (Estevez et al., 2012;
Morgan et al., 2010). Previously, we showed the dithiol glutar-
edoxin, GLRX-21 was required for GSH to exert these protective
effects (Estevez et al., 2012; Morgan et al., 2010). When daf-
16(mu86) animals were concomitantly exposed to Se(IV) and GSH,
they responded no differently than WT, i.e. GSH was able to
partially rescue the movement deﬁcits observed with Se(IV)
exposure alone at all the time points tested (Fig. 6) as was
previously shown for WT animals (Morgan et al., 2010). This
improvement was observed across all the time points tested for the
daf-16 lf animals. Although the improvement observed in WT
animals was only signiﬁcant at the 72 h time point here, we had
previously observed differences at both 24 and 48 h depending on
dosage (Morgan et al., 2010). Thus, this data suggests that DAF-16
is not required for GSH to provide protection from high dose Se(IV)
exposure.
Hydrogen peroxide induced oxidation of PTEN has been shown
to be reduced by glutathione in yeast and human cells (Kim et al.,
A.O. Estevez et al. / NeuroToxicology 41 (2014) 28–43 392011) while oxidative stress signiﬁcantly increased levels of GSH in
cells from patients with a missense mutation in PINK1 in
comparison to controls (Gru¨newald et al., 2009). When animals
with the pink-1 or daf-18 mutations were treated with GSH, they
did not respond favorably; none of these animals showed
improved percentages of animals moving normally after treatment
(Fig. 6). In fact when both sets of animals were exposed to Se(IV), at
24 h the GSH-treated daf-18(e1375) animals showed a signiﬁcant
reduction in the percentage of animals moving normally in
comparison to animals not treated with GSH (Fig. 6). At later time
points, both daf-18 mutant animals showed a trend downward in
response to GSH treatment although it was not signiﬁcant (Fig. 6).
Thus, both PTEN and PINK1 appear to be required for GSH to
ameliorate the Se(IV)-induced motility deﬁcits.
4. Discussion
We have shown previously that exposures to high levels of
selenium [Se(IV)] in the environment of adult animals can induce
neurodegeneration and cell loss resulting in motor deﬁcits and
death (Estevez et al., 2012; Morgan et al., 2010) and that this is at
least partially caused by a reduction in cholinergic signaling across
the neuromuscular junction (Estevez et al., 2012). Here we provide
evidence that a reduction in the insulin/insulin-like (IIS) stress
response pathway regulates the response to high dose levels ofFig. 7. Summary model of the effects of sodium selenite in C. elegans. Adult animals with m
Se(IV) within their environment similar to that observed when exposed to other stressor
an opposite phenotype from that of many of the upstream components that inhibit its nuc
or resistance phenotypes were not. A model depicting the effects of Se(IV) on the IGFR si
presented here as well as previously by us (Morgan et al., 2010), and elsewhere (Luo et a
Mei et al., 2009; Budovskaya et al., 2008). The Se(IV) (selenite) responsive phenotypes, lis
reduction-of-function mutants. *R, resistance phenotype of reduction-of-function mutan
lines represent pathways that are assumed based on data observed in other organisms,
PI3K = phosphatidylinositide 3-kinase; FOXO = forkhead box transcription factor; PTEN
glutathione; Ref. 1 = Ponugoti et al. (2012); Ref. 2 = Kim et al. (2011), Loh et al. (2009); Ref
6 = Akundi et al. (2012).environmental selenium which in turn regulates the IIS pathway.
Most speciﬁcally we show that nuclear localization and thus
activation of the DAF-16/forkhead box transcription factor occurs
in response to Se(IV) exposure although this was not observed in
motor neurons of the ventral cord. Yet, tissue speciﬁc expression
and generalized overexpression of DAF-16 can partially rescue the
neurodegenerative and behavioral deﬁcits observed with high
dose Se(IV) exposures. In addition, we determined that two
modiﬁers of AKT activation, PINK1 and PTEN are required for the
cellular antioxidant glutathione to mitigate the Se(IV)-induced
movement deﬁcits, previously shown to also require the dithiol
glutaredoxin, GLRX-21 (Morgan et al., 2010). The data presented
here and previously are summarized in Fig. 7.
Overexpression of DAF-16 under native promoter control leads
to the partial rescue of the Se(IV)-induced effects on movement
and neurodegeneration (Table 1 and Fig. 2G; Fig. 4A) while loss of
daf-16 had the opposite effect on both phenotypes (Table 1; Fig.
2G). This suggests a neuroprotective role for DAF-16 during Se(IV)-
induced toxicosis in C. elegans (Fig. 7). Gene expression through
activation of DAF-16 prevents ROS-induced neuronal degeneration
(Calixto et al., 2012), as well as protects from neurodegeneration in
worm models of Huntington’s (Parker et al., 2012), and motor
neuron diseases (Mojsilovic-Petrovic et al., 2009). Yet, surprisingly
neuron-speciﬁc expression of DAF-16 did not fully rescue the
movement deﬁcits (Fig. 3A). Limiting expression of DAF-16 to theutations in components of the DAF-2/IGFR signaling cascade responded to high dose
s (Honda and Honda, 2002), i.e. the loss- or reduction-of-function daf-16 alleles had
lear translocation. Yet, although the pattern was predictable, the speciﬁc sensitivity
gnaling cascade including modulatory branches is shown and summarizes the data
l., 2013; Akundi et al., 2012; Ponugoti et al., 2012; Kim et al., 2011; Loh et al., 2009;
ted in parentheses as R (resistant) or S (sensitive), are based on the phenotypes of the
t is assumed since the mg144 gain-of-function mutation is sensitive (Fig. 1); Dotted
 but not conﬁrmed in C. elegans. IGFR = insulin/insulin growth factor-like receptor;
 = phosphatase and tensin homolog; GSH = reduced glutathione; GSSG = oxidized
. 3 = Mei et al. (2009); Ref. 4 = Luo et al. (2013); Ref. 5 = Budovskaya et al. (2008); Ref.
A.O. Estevez et al. / NeuroToxicology 41 (2014) 28–4340intestines on the other hand fully rescued the movement deﬁcits,
but only for the ﬁrst 24 h after exposure (Fig. 3A). If DAF-16 can
function non-cell autonomously as previously suggested (Iser
et al., 2007; Libina et al., 2003), then it is possible that intestinal
expression of DAF-16 could result in secretion of a diffusible factor
that activates DAF-16 within the motor neurons preventing the
movement deﬁcits normally observed with Se(IV) exposure
(Morgan et al., 2010). Yet, the inability to detect DAF-16 nuclear
localization in motor neurons (Fig. 4B) after Se(IV) exposure
although localization in other cell types was observed (Fig. 2C–F;
Fig. 4B) does not seem to support this notion, but suggests another
possibility. Activation of DAF-16 in hypodermal tissue was
observed by Qi et al. (2012) to affect germ-line proliferation
without activating DAF-16 in the gonad, thus DAF-16 activation in
the intestine may similarly non-autonomously protect the motor
neurons without activating DAF-16 in these neurons. Our
observation that the level of DAF-16 expression could affect the
amount of damage to the motor neurons and the ventral cord with
Se(IV)-exposure (Fig. 4A) without inducing detectable transloca-
tion of DAF-16 into the neurons (Fig. 4B) seems to support this
hypothesis.
The sod-3 gene is reported to be a direct target of the DAF-16
transcriptional activation (Oh et al., 2006) and is required by DAF-
16 for oxidative stress response (Honda et al., 2010). Yet, if
activation of the sod-3 gene occurred in response to DAF-16
transcription, than sod-3 mutant animals would be expected to
have the same phenotype as the daf-16(-) animals in response to
Se(IV)-exposure. We did not observe this to be the case since the
sod-3 mutant animals were resistant to Se(IV) while the daf-16
mutant animals were more sensitive (compare Fig. 5A to Figs. 1A
and 2G). In addition, overexpression of SOD-3 did not appear to
prevent the Se(IV)-induced neurodegeneration in the motor
neurons (Fig. 5B) although overexpression of DAF-16 did partially
rescue this effect (Fig. 4A). Given this result it seems unlikely that
sod-3 expression is activated by DAF-16 in response to high dose
Se(IV) exposures. In addition, transcriptional repression of sod-3
expression by DAF-16 is unlikely since SOD-3 expression was
observed in both the GABAergic and cholinergic motor neurons
(Fig. 5B) and DAF-16 was not (Fig. 4B). Thus, the data presented
here would suggest that SOD-3 expression in the motor neurons is
regulated by a transcription factor other than DAF-16. Indeed SOD-
3 expression in other cells has been reported to be regulated by the
GATA transcription factor ELT-3 (Budovskaya et al., 2008). Further
studies aimed at examining motor neuron expression of SOD-
3::GFP in the background of animals with mutations in other
transcription factors would address this issue, but is outside the
scope of this paper.
PINK1 and PTEN have both been shown to be induced by
FOXO3a transcription (Luo et al., 2013; Mei et al., 2009) and
although it is possible that such an interaction occurs in worms, it
has not been demonstrated. Here we report that loss or reduction
of either daf-18/PTEN or pink-1 results in a decreased percentage of
normal moving animals when either strain is exposed to Se(IV). Yet
although the daf-18/PTEN animals were signiﬁcantly more sensi-
tive to Se(IV) than was WT [i.e. daf-18 mutant animals were Se(IV)-
sensitive], the pink-1 animals were no worse than WT (Fig. 6). The
similarity of the phenotypes displayed by the daf-18/PTEN and the
daf-16 mutant animals in response to Se(IV) exposure suggests the
possibility that daf-18 is transcriptionally regulated by daf-16 (Fig.
7) although further studies would need to be performed to conﬁrm
this. PINK1 was initially identiﬁed as a PTEN inducible kinase
(Valente et al., 2004) which was more recently shown to be
regulated by PTEN through its inhibition of AKT signaling and
subsequent activation of FOXO3a transcription of the PINK1 gene
(Mei et al., 2009). In addition to being induced by PTEN, PINK1 has
also been shown to induce AKT phosphorylation and thesubsequent inactivation of FOXO3a (Fig. 7) (Akundi et al., 2012).
Thus, loss of PINK1 in C. elegans may not induce an increased
Se(IV)-sensitivity phenotype simply because phosphorylation of
AKT by PINK1 can be achieved by other kinases including PDK-1
and mTOR (Sa´nchez-Mora et al., 2012; Murata et al., 2011; Maj
et al., 2010; Paradis et al., 1999).
The loss of pink-1 or daf-18/PTEN was here shown to produce a
GSH insensitivity phenotype (Fig. 6) which had only previously
been observed by loss of GLRX-21, the glutaredoxin 2 (GRX)2-like
protein (Estevez et al., 2012; Morgan et al., 2010). ROS has been
demonstrated to oxidize and thus inactivate PTEN and this process
requires both GRX and GSH to be reduced (Kim et al., 2011). Thus, a
similar mechanism may occur in C. elegans accounting for the GSH
insensitivity phenotype of the daf-18 mutants (Fig. 7). Loss of
PINK1 was observed to lead to a dramatic decrease in GSH levels
(Mei et al., 2009), as well as an increase in the activity of the
enzyme glutathione S-transferase (GST) (Hoepken et al., 2007).
GST has been shown to increase in response to high levels of
sodium selenite (Sun et al., 2013; Zhang et al., 2008). Thus, the
inability of exogenous GSH to improve movement in the pink-1
mutant animals may reﬂect an increase in catabolism of GSH
through the increased activities of GST. Further studies examining
the GST levels in both WT and pink-1 mutants would be able to
address this issue in more depth.
Selenite can induce mitochondrial fragmentation in glioma
cells (Kim et al., 2007) and was shown here to induce
mitochondrial fragmentation in muscles and neurons (Figs. 3B
and 5B, respectively). Overexpression of Mn-SOD was shown to
prevent this selenite-induced mitochondrial damage in the glioma
cells, but in C. elegans overexpression of the SOD-3/Mn-SOD
protein did not (Fig. 5B). The increased expression of the D2-like
dopamine receptor DOP-3 observed in muscle after Se(IV)
exposure (Fig. 5B) might represent an attempt to alter the
mitochondrial damage induced by Se(IV) even though the DOP-
3::RFP was not observed to co-localize with the SOD-3 expression
in the mitochondria (compare outlines Fig. 5B). Examining the
effects of D2 receptor activation in a Parkinson’s model, Chau et al.
(2009) showed receptor activation improved mitochondrial
membrane potential and up-regulated intracellular levels of
GSH. Thus the upregulation of DOP-3 observed in the muscle
may be an attempt to stabilize the mitochondria and prevent
mitochondrial damage. This question could not be directly
addressed within the context of these studies since the DOP-3
construct used was a promoter fusion only and not a rescuing clone
(Chase et al., 2004).
5. Conclusion
Here we present more extensive evidence that high dose
exposures to sodium selenite can induce neurodegeneration and
demonstrate damage of both the cholinergic and GABAergic motor
neurons in the ventral cord. Reductions in both cholinergic and
GABAergic signaling were previously shown to alter normal
movement. Similarly, movement deﬁcits were observed to occur
with reductions in insulin/insulin-like signaling that are known to
activate DAF-16/forkhead box-3a and increased expression of DAF-
16 was shown to both improve movement and reduce neurode-
generation. This suggests that DAF-16 alters expression of genes
that are neuroprotective against the toxic insult of high dose
selenium exposure. Two gene products that are known to be
regulated by forkhead box transcription, PINK1 and PTEN were
shown here to be required for the cellular anti-oxidant reduced
glutathione to reduce the neurodegenerative effects on movement
while overexpression of a third gene, sod-3 known to be regulated
in C. elegans by DAF-16 did not alter the neurodegenerative
process. Taken together these data suggest a link between toxicant
A.O. Estevez et al. / NeuroToxicology 41 (2014) 28–43 41exposures and complex regulation of signaling processes that can
alter the course of neurological decline. That environmental
exposures can lead to ALS or other neurological diseases is
suspected through previous observations, and this model of
selenium-induced neurodegeneration developed in a genetically
tractable organism provides a tool for examining the combined
roles of genetics and environment in neuro-pathologic disease
progression.
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